As of October 27, 2026, 3 holders' latest Schedule 13D or 13G filings report owning 5% or more of Capstone Energy+, Inc. The largest reported stake is Monarch Alternative Capital LP's, at 39.8%. 6 filings are on record since January 27, 2026 (Schedule 13D/A, October 26, 2026).
Sell to companies like Capstone Energy+, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Holder: Monarch Alternative Capital LP · Percent: 39.8% · SCHEDULE 13D/A
- · Holder: Lytton Laurence W · Percent: 5.4% · SCHEDULE 13G/A
- · Holder: Monarch Alternative Capital LP · Percent: 40.1% · SCHEDULE 13D/A
- · Holder: Monarch Alternative Capital LP · Percent: 42.1% · SCHEDULE 13D
- · Holder: Orin Hirschman · Percent: 9.9% · SCHEDULE 13G/A
Capstone Energy+, Inc. has 6 Schedule 13D or 13G filings on record since 2026-01-27. 3 holders' latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Monarch Alternative Capital LP | 39.8% | 19,333,334 | SCHEDULE 13D/A, 2026-10-26 | 2026-10-23 |
| 9.9% | 2,280,000 | SCHEDULE 13G/A, 2026-02-02 | 2025-12-31 | |
| 5.4% | 1,746,561 | SCHEDULE 13G/A, 2026-08-13 | 2026-06-30 |
Holding shares or following this stake? See who's behind Capstone Energy+, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Capstone Energy+, Inc. and the records around it.
Capstone Energy+, Inc. elsewhere on the record
- Leadership changes Oct 2026
- Company profile and every filing Apr 2026
- Form D filing Apr 2026
- Form D filing Dec 2025
- Who owns it
Companies that share a holder
- LYTTON LAURENCE W also filed stake reports on 28 other companies: Retension Pharmaceuticals, Inc. (Oct 2026), Rank One Computing Corp (Aug 2026), MDxHealth SA (Aug 2026)
- Orin Hirschman also filed stake reports on 46 other companies: Bionano Genomics, Inc. (Oct 2026), Clearfield, Inc. (Oct 2026), FENNEC PHARMACEUTICALS INC. (Oct 2026)
Watch Capstone Energy+, Inc.
Get an email when Capstone Energy+, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Capstone Energy+, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Capstone Energy+, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Capstone Energy+, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Purpose of Transaction (Item 4)
Monarch Alternative Capital LP
Item 4 of the Schedule 13D is hereby amended to add the following: As previously disclosed, the Monarch Funds have certain rights to appoint two individuals as directors of the Issuer. On October 23, 2026, the Monarch Funds designated Brandon Schwertner for appointment to the Board as a Series A Director pursuant to the Certificate of Designation. Mr. Schwertner's appointment was approved by the Board on October 26, 2026. In addition, the Issuer has outstanding secured notes due December 7, 2026 (the "Notes"), which Notes were issued under the Note Purchase Agreement, dated December 7, 2023, by and among the Issuer's operating subsidiary and the purchasers party thereto. The Reporting Persons intend to discuss with the Issuer various options with respect to the forthcoming maturity of the Notes, which discussions may include proposals that may address, among other things, the terms, structure and timing of potential refinancing of the Notes and the potential participation of the Reporting Persons or their affiliates in any refinancing. Any such proposals, and any resulting transaction, may relate to or result in one or more of the matters described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. As of the date of this Amendment, the Reporting Persons have not reached any agreements or made any offers to the Issuer in respect of the Notes. There can be no assurance that any offer will be made, nor that the Issuer or the Reporting Persons will agree to any …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-10-26; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-01-27 | Lytton Laurence W | 7.7% | SCHEDULE 13G |
| 2026-02-02 | Orin Hirschman | 9.9% | SCHEDULE 13G/A |
| 2026-04-03 | Monarch Alternative Capital LP | 42.1% | SCHEDULE 13D |
| 2026-06-29 | Monarch Alternative Capital LP | 40.1% | SCHEDULE 13D/A |
| 2026-08-13 | Lytton Laurence W | 5.4% | SCHEDULE 13G/A |
| 2026-10-26 | Monarch Alternative Capital LP | 39.8% | SCHEDULE 13D/A |
Capstone Energy+, Inc.: every filing and event
Tools for this story
Each opens in a new tab, filled in for Capstone Energy+, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.